Publishing: Journals, books and databases
Encompassing all aspects of synthetic and biological macromolecules, and related emerging areas
Impact Factor 5.52 48 Issues per Year
Review Article

FDA-approved poly(ethylene glycol)–protein conjugate drugs

Corresponding authors
Department of Chemistry & Biochemistry and the California NanoSystems Institute, University of California, 607 Charles E. Young Dr East, Los Angeles, USA
Ronald Reagan UCLA Medical Center, Division of Cardiology, 757 Westwood Plaza, Los Angeles, USA
Polym. Chem., 2011,2, 1442-1448

DOI: 10.1039/C1PY00034A
Received 21 Jan 2011, Accepted 20 Mar 2011
First published online 27 Apr 2011

This article is part of themed collection: Polymer Bioconjugates
| | | | | | More
Please wait while Download options loads